microRNA-141 as a diagnostic and prognostic biomarker for prostate cancer in Egyptian population: Pilot study
Authors:
- R. AliRAR. Ali
- S. El TabbakhSTS. El Tabbakh
- W. El DelgawyWDW. El Delgawy
- A. KotbAKA. Kotb
- M.N. DesoukyMDM.N. Desouky
Open Access
- 1 December 2018
- journal article
- research article
- Published by Springer Nature in African Journal of Urology
- Vol. 24 (4) , 347-352
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional StudiesPLOS ONE, 2016
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Circulating MicroRNAs: Potential Biomarkers for CancerInternational Journal of Molecular Sciences, 2011
- Metastamirs: a stepping stone towards improved cancer managementNature Reviews Clinical Oncology, 2010
- miR-21 as a key regulator of oncogenic processesBiochemical Society Transactions, 2009
- MicroRNAs: Novel Biomarkers for Human CancerClinical Chemistry, 2009
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialJNCI: Journal of the National Cancer Institute, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994